EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

9-cis-Retinoic Acid Improves Disease Modelling in iPSC-Derived Liver Organoids

Mina Kazemzadeh Dastjerd iD, Vincent Merens iD, Ayla Smout, Rebeca De Wolf iD, Christophe Chesné iD, Catherine Verfaillie, Stefaan Verhulst, Leo A van Grunsven iD

Cells · 26.06.2025 · 14 (13) · 983

DOI: 10.3390/cells14130983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 26.06.2025. Verfasst von Mina Kazemzadeh Dastjerd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1090 Brussel, Belgium. Hauptthemen laut MEDLINE: Organoids, Induced Pluripotent Stem Cells, Liver, Tretinoin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation - Flanders, European Union, Fund of Scientific Research Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis majorly impacts global health, necessitating the development of in vitro models to study disease mechanisms and develop drug therapies. Relevant models should at least include hepatocytes and hepatic stellate cells (HSCs) and ideally use three-dimensional cultures to mimic in vivo conditions. Induced pluripotent stem cells (iPSCs) allow for patient-specific liver modelling, but current models based on iPSC-derived hepatocytes (iHepatocytes) and HSCs (iHSCs) still lack key functions. We developed organoids of iHepatocytes and iHSCs and compared them to HepaRG and primary HSC organoids. RNA sequencing analysis comparison of these cultures identified a potential role for the transcription factor RXRA in hepatocyte differentiation and HSC quiescence. Treating cells with the RXRA ligand 9-cis-retinoic acid (9CRA) promoted iHepatocyte metabolism and iHSC quiescence. In organoids, 9CRA enhanced fibrotic response to TGF-β and acetaminophen, highlighting its potential for refining iPSC-based liver fibrosis models to more faithfully replicate human drug-induced liver injury and fibrotic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsInduced Pluripotent Stem CellsLiverTretinoinModels, BiologicalHumansHepatocytesCell DifferentiationHepatic Stellate CellsLiver Cirrhosis

Stichwörter der Autor:innen

DILIdrug metabolismhepatic stellate cell activationhepatocytesiPSCliver fibrosis

Substanzen

Tretinoin

Autor:innen und Institutionen

  • Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1090 Brussel, Belgium.
  • Biopredic International SARL, Parc de la Bretech, 35760 Saint Grégoire, France.
  • Stamcelinstituut Leuven, KU Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Mina Kazemzadeh Dastjerd, Vincent Merens, Rebeca De Wolf, Christophe Chesné, Leo A van Grunsven

Förderung

  • Research Foundation - Flanders
  • European Union
  • Fund of Scientific Research Flanders
  • The European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Kazemzadeh Dastjerd, M., Merens, V., Smout, A., De Wolf, R., Chesné, C., Verfaillie, C., Verhulst, S., & van Grunsven, L. A. (2025). 9-cis-Retinoic Acid Improves Disease Modelling in iPSC-Derived Liver Organoids. Cells, 14(13), 983. https://doi.org/10.3390/cells14130983

Vancouver

Kazemzadeh Dastjerd M, Merens V, Smout A, De Wolf R, Chesné C, Verfaillie C, et al. 9-cis-Retinoic Acid Improves Disease Modelling in iPSC-Derived Liver Organoids. Cells. 2025;14(13):983. doi:10.3390/cells14130983

BibTeX
@article{KazemzadehDastjerd2025,
  author = {Kazemzadeh Dastjerd, Mina and Merens, Vincent and Smout, Ayla and De Wolf, Rebeca and Chesné, Christophe and Verfaillie, Catherine and Verhulst, Stefaan and van Grunsven, Leo A},
  title = {9-cis-Retinoic Acid Improves Disease Modelling in iPSC-Derived Liver Organoids},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {13},
  pages = {983},
  doi = {10.3390/cells14130983}
}
Kostenlos starten →